School of Life Science and Technology, Xidian University, Xi'an, Shaanxi, 710071, China.
Department of Radiology, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, 710068, China.
Sci Rep. 2019 Mar 14;9(1):4429. doi: 10.1038/s41598-019-40831-z.
It is difficult to accurately assess axillary lymph nodes metastasis and the diagnosis of axillary lymph nodes in patients with breast cancer is invasive and has low-sensitivity preoperatively. This study aims to develop a mammography-based radiomics nomogram for the preoperative prediction of ALN metastasis in patients with breast cancer. This study enrolled 147 patients with clinicopathologically confirmed breast cancer and preoperative mammography. Features were extracted from each patient's mammography images. The least absolute shrinkage and selection operator regression method was used to select features and build a signature in the primary cohort. The performance of the signature was assessed using support vector machines. We developed a nomogram by incorporating the signature with the clinicopathologic risk factors. The nomogram performance was estimated by its calibration ability in the primary and validation cohorts. The signature was consisted of 10 selected ALN-status-related features. The AUC of the signature from the primary cohort was 0.895 (95% CI, 0.887-0.909) and 0.875 (95% CI, 0.698-0.891) for the validation cohort. The C-Index of the nomogram from the primary cohort was 0.779 (95% CI, 0.752-0.793) and 0.809 (95% CI, 0.794-0.833) for the validation cohort. Our nomogram is a reliable and non-invasive tool for preoperative prediction of ALN status and can be used to optimize current treatment strategy for breast cancer patients.
评估乳腺癌患者腋窝淋巴结转移和诊断腋窝淋巴结具有一定难度,且术前具有侵袭性和低敏感性。本研究旨在开发一种基于乳腺 X 线摄影术的放射组学列线图,用于预测乳腺癌患者腋窝淋巴结转移。本研究纳入了 147 例经临床病理证实的乳腺癌患者和术前乳腺 X 线摄影术。从每位患者的乳腺 X 线摄影图像中提取特征。采用最小绝对收缩和选择算子回归方法在主要队列中选择特征并构建特征签名。采用支持向量机评估特征签名的性能。我们通过将特征签名与临床病理危险因素相结合,开发了一个列线图。通过在主要和验证队列中评估其校准能力来估计列线图的性能。特征签名由 10 个选定的与腋窝淋巴结状态相关的特征组成。主要队列中特征签名的 AUC 为 0.895(95%CI,0.887-0.909),验证队列为 0.875(95%CI,0.698-0.891)。主要队列中列线图的 C-Index 为 0.779(95%CI,0.752-0.793),验证队列为 0.809(95%CI,0.794-0.833)。我们的列线图是一种用于预测腋窝淋巴结状态的可靠、非侵入性工具,可用于优化当前乳腺癌患者的治疗策略。